| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/17/2007 | US7244818 Interferon alpha responsive protein |
| 07/17/2007 | US7244814 Variant Tat proteins and methods for use thereof |
| 07/17/2007 | US7244708 Inhibitors of memapsin 2 and use thereof |
| 07/17/2007 | US7244704 Exploiting endogenous import and export mechanisms of ribonucleic acid trafficking which utilize nuclear targeting peptides containing nonclassical nuclear localization signals |
| 07/17/2007 | US7244617 Generating transgenic cell comprising expression vector coding apotosis inducing factor for use in treatment of cell proliferative and viral disorders |
| 07/17/2007 | US7244616 Mammalian host cells for enhanced expression of a recombinant protein; bioreactors and genetic engineering |
| 07/17/2007 | US7244615 Producing an antibody comprising complementarity determining regions, heavy and light chains, and non-human donor residues, a variable domain; used for in vivo therapy and diagnosis |
| 07/17/2007 | US7244614 Fusion proteins and assays for molecular binding |
| 07/17/2007 | US7244613 Expression vector comprising nucleotide sequences coding tubercular complex for use in developing vaccines for treatment and prevention of respiratory system disorders; bactericides |
| 07/17/2007 | US7244610 Aerobic succinate production in bacteria |
| 07/17/2007 | US7244609 Synthetic genes and bacterial plasmids devoid of CpG |
| 07/17/2007 | US7244606 Genetically engineered beta-site amyloid precursor protein-cleaving enzyme having the modification Pro33Lys at position 33 for prevention, diagnosis and treatment of neurodegenerative and alzheimer's diseases |
| 07/17/2007 | US7244605 Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
| 07/17/2007 | US7244604 HDAC9 polypeptides and polynucleotides and uses thereof |
| 07/17/2007 | US7244603 Purified HpyC1I and its use as a restriction endonuclease |
| 07/17/2007 | US7244602 Polymerase chimeras |
| 07/17/2007 | US7244601 Nucleotide sequences coding enzymatic polypepties for use in development of anticarcinogenic agents |
| 07/17/2007 | US7244600 Glucose dehydrogenase |
| 07/17/2007 | US7244599 Gene and uses therefor to modify pasture qualities of crops |
| 07/17/2007 | US7244597 Secondary liquefaction in ethanol production |
| 07/17/2007 | US7244595 Method of maintaining or improving a nitrile hydratase activity |
| 07/17/2007 | US7244593 Microorganisms and processes for enhanced production of pantothenate |
| 07/17/2007 | US7244592 Identifying immunoglobulins for use as therapeutic, diagnostic an/or affinity separation agents; in vitro translation |
| 07/17/2007 | US7244591 Yeast transformant producing recombinant human parathyroid hormone and method for producing the hormone |
| 07/17/2007 | US7244590 Regulatory protein for Nox enzymes |
| 07/17/2007 | US7244589 Chimeric immunogens |
| 07/17/2007 | US7244588 Cold-induced expression vector |
| 07/17/2007 | US7244587 Expression vectors encoding bacteriophage signal peptides |
| 07/17/2007 | US7244586 Also recombinant vectors and hosts that contain the molecule, purified formes of the ion channel proteins and recombinant membrane fractions; identifying modulators of the proteins, which will be useful as insecticides. |
| 07/17/2007 | US7244585 Producing a recombinant or chimeric GBV-B virus by introducing into a host cell a genome composed of a 3' terminal sequence of GBV-B and culturing the host cell to produce the virus from the genome. |
| 07/17/2007 | US7244584 T2R, a novel family of taste receptors |
| 07/17/2007 | US7244581 Glucose dehydrogenase |
| 07/17/2007 | US7244569 Plasmid autonomously replicable in coryneform bacteria |
| 07/17/2007 | US7244567 Annealing an unblocked primer to a first strand of nucleic acid; annealing a second blocked primer to a second strand of nucleic acid; elongating the nucleic acid along the first strand with a polymerase; terminating the first sequencing primer; deblocking the second primer; and elongating nucleic acid |
| 07/17/2007 | US7244564 High Mobility Group A (HMGA); genetic markers for animal growth, fatness, meat quality, and feed efficiency, methods for identifying such markers, and methods of screening animals to determine those more likely to produce these desired traits |
| 07/17/2007 | US7244563 Genes for plant fatty acid modifying enzymes associated with conjugated double bond formation |
| 07/17/2007 | US7244561 Inhibiting denaturation of nucleic acid duplexes |
| 07/17/2007 | US7244560 Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites |
| 07/17/2007 | US7244559 Sequences determination of preferential nucleotide sequences; provide primers and nucleotide sequence patterns, mix, anneal primer to nucleotide sequences, mix nucleotides, determine sequence of sample |
| 07/17/2007 | US7244434 Expresses all structural proteins of a pestivirus (e.g., BVDV) except for a functional C protein; coding sequences for a signal sequence within the C protein essential for post translational processing are retained or replaced by a sequence for analogous signal sequences from another pestiviral species |
| 07/17/2007 | US7244433 Immunogens; replication-defective; antibodies; host cells; kits |
| 07/17/2007 | US7244429 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 07/17/2007 | US7244425 Acid- and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol |
| 07/17/2007 | US7244422 Enhancing the effect of hepatitis vaccines, particularly hepatitus B vaccines, by the use of ribavirin as an adjuvant; single administration |
| 07/17/2007 | US7244410 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 07/17/2007 | CA2372665C Process for high throughput dna methylation analysis |
| 07/17/2007 | CA2309831C Improved methods and systems for performing molecular separations |
| 07/17/2007 | CA2305655C Self-deleting vectors for cancer therapy |
| 07/17/2007 | CA2231436C Neural transplantation using pluripotent neuroepithelial cells |
| 07/17/2007 | CA2185340C Expression of bacillus thuringiensis cry proteins in plant plastids |
| 07/17/2007 | CA2182013C Humanized antibodies against leukocyte adhesion molecule vla-4 |
| 07/17/2007 | CA2162250C Methods of typing hepatitis c virus and reagents for use therein |
| 07/17/2007 | CA2145535C Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
| 07/17/2007 | CA2102594C Gene manipulation and expression using genomic elements |
| 07/16/2007 | CA2533052A1 Isolating both free and protein associated dna |
| 07/12/2007 | WO2007079224A2 Sirna compositions promoting scar-free wound healing of skin and methods for wound treatment |
| 07/12/2007 | WO2007078439A2 Electrofusion microelectrode and methods of using it to manipulate cells and/or cellular components |
| 07/12/2007 | WO2007078286A2 Nucleotide sequences and corresponding polypeptides conferring modulated plant growth rate and biomass in plants |
| 07/12/2007 | WO2007078280A2 Transgenic plants with enhanced agronomic traits |
| 07/12/2007 | WO2007078239A2 Spider silk proteins and methods for producing spider silk proteins |
| 07/12/2007 | WO2007078127A1 Method for cell surface displaying of target proteins using bacillus anthracis exosporium |
| 07/12/2007 | WO2007077997A1 Ultrasonic substance-introduction method, apparatus for the method, and medical diagnostic imaging apparatus |
| 07/12/2007 | WO2007077977A1 Composition and method for predicting the postoperative prognosis or metastatic risk of cancer patient |
| 07/12/2007 | WO2007077464A2 Chicken virus vaccine and diagnostic |
| 07/12/2007 | WO2007077423A2 Growth hormone variations |
| 07/12/2007 | WO2007077398A2 Gene promoters that can be used in plants |
| 07/12/2007 | WO2007077339A1 Interfering rnas targeting the morbillivirus nucleoprotein gene |
| 07/12/2007 | WO2007077316A1 Method for preventing and/or treating articles or media contaminated with bacteria of the legionella genus |
| 07/12/2007 | WO2007077008A1 Chimaeric fusion protein with superior chaperone and folding activities |
| 07/12/2007 | WO2007076950A1 Anti-cd19 antibodies with reduced immunogenicity |
| 07/12/2007 | WO2007076933A1 Interleukin-12p40 variants with improved stability |
| 07/12/2007 | WO2007076927A1 Anti-il-6 antibodies preventing the binding of il-6 complexed with il-6ralpha to gp130 |
| 07/12/2007 | WO2007076727A1 A rice gene, gs3, exerting primary control over grain length and grain weight |
| 07/12/2007 | WO2007076726A1 Methods for nucleic acid mapping and identification of fine-structural-variations in nucleic acids and utilities |
| 07/12/2007 | WO2007062107A3 Immunostimulatory oligoribonucleotides |
| 07/12/2007 | WO2007059041A3 Combinations and methods of using an immunomodulatory oligodeoxynucleotide |
| 07/12/2007 | WO2007058992A3 Mutations and polymorphisms of hdac6 |
| 07/12/2007 | WO2007058843A3 Web based vector design |
| 07/12/2007 | WO2007053184A3 Methods for producing micrornas |
| 07/12/2007 | WO2007045930A3 Modulation of trpv expression levels |
| 07/12/2007 | WO2007045019A3 Polyoleosins |
| 07/12/2007 | WO2007044394A3 Compositions and methods for treatment of autoimmune disease |
| 07/12/2007 | WO2007042899A3 Human microrna targets in hiv genome and a method of identification thereof |
| 07/12/2007 | WO2007030674A3 Use of nucleases to improve viability and enhance transgene expression in transfected cells |
| 07/12/2007 | WO2007028396A3 Cell nuclear transfer |
| 07/12/2007 | WO2007025097A3 Use |
| 07/12/2007 | WO2007021933A3 Methods and compositions for use in treating vascular diseases and conditions |
| 07/12/2007 | WO2007019094A3 Modified influenza virus for monitoring and improving vaccine efficiency |
| 07/12/2007 | WO2007018544A3 Tri-block copolymers for nanosphere-based drug delivery |
| 07/12/2007 | WO2007017759A3 Creating poultry and other animals resistant to viral disease |
| 07/12/2007 | WO2007016566A3 Production of reprogrammed cells with restored potential |
| 07/12/2007 | WO2007016488A3 Analysis of encoded chemical libraries |
| 07/12/2007 | WO2007014304A3 Antibody profiles characteristic of tuberculosis state |
| 07/12/2007 | WO2007012934A3 Methods for identifying genes that increase yeast stress tolerance, and use of these genes for yeast strain improvement |
| 07/12/2007 | WO2007011771A3 Yield increase in plants overexpressing the mtp genes |
| 07/12/2007 | WO2007002321A3 Prrs viruses, infectious clones, mutants thereof, and methods of use |
| 07/12/2007 | WO2007002261A3 IL-1β BINDING ANTIBODIES AND FRAGMENTS THEREOF |
| 07/12/2007 | WO2007001183A3 Hecgf-1 related polymorphisms and applications thereof |
| 07/12/2007 | WO2006138627A3 Monoclonal antibodies recognizing a coagulase-negative staphylococcal protein |
| 07/12/2007 | WO2006128141A3 Rna interference mediated inhibition of stromal cell-derived factor-1 (sdf-1) gene expression using short interfering nucleic acid (sina) |